Analyst Stance On Two Stocks: GenMark Diagnostics, Inc. (GNMK), Globant S.A. (GLOB)

The recently concluded session had traders exchanging GenMark Diagnostics, Inc. (NASDAQ:GNMK) low level. Roughly 0.33 million shares changed hands compared to the three-month volume average 0.66 million shares. The first trade took place at $4.74 and the stock went down -1.49% to attain the closing price of $4.64.

GenMark Diagnostics, Inc. (GNMK) Analyst Opinion

GenMark Diagnostics, Inc. has a consensus outperform rating from 8 Wall Street analysts, and the number of shares currently sold short amount to at least 17.37% of shares outstanding. The stock sank -40.66% last month and is down -62.09 this year. Wall Street is only getting more bullish on the stock, with 7 of analysts who cover GNMK having a buy-equivalent rating. Analysts have placed a $11 price target on GenMark Diagnostics, Inc., suggesting a 137.07% gain from recent close. It’s currently trading about -66.06% below its 52-week high.

GenMark Diagnostics, Inc. Earnings Surprise

GenMark Diagnostics, Inc. (GNMK) failed to surprise the stock market in its last reported earnings when it earned -$0.28 a piece versus the consensus-estimated -$0.26. Its revenue totaled $14.56 million up 17.8% from the previous quarter.

GenMark Diagnostics, Inc. (NASDAQ:GNMK) Intraday View

This stock (GNMK) is ahead of its 52-week low with 27.82%. Its last month’s stock price volatility remained 4.97% which for the week stands at 9.7%. The share price has moved backward from its 20 days moving average, trading at a distance of -17.72% and stays -39.93% away from its 50 days moving average. Over the last five days, shares have faced -4.53% losses and now is down -57.16% since hitting its 200-day moving average of $10.14. GenMark Diagnostics, Inc. (GNMK) has made its way to a 12-month decline of -60.21%.

Turning to Globant S.A. (NYSE:GLOB), its shares were trading at $40.25 a retreat of $-0.5, on the trading floor. The stock, after opening at $40.7, touched a high of $40.97 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2.2. Globant S.A. has 3 buy ratings, 3 holds and 1 sells even after the stock tumbled -15.28% from its high of $47.51 to a $1.24 billion market value through last close.

Globant S.A. (GLOB) Consensus Price Target

The company’s consensus rating on Reuter’s scale remained unchanged from 2.33 to 2.33 during a month. Analysts set a 12-month price target of $41.43 a share. The target implies a 2.93% spike from where the shares are currently trading. Also, the current price highlights a discount of 24.22% to analysts’ high consensus price target.

Globant S.A. (NYSE:GLOB) Intraday Trading

The counter witnessed a trading volume of 0.28 million shares versus an average volume of 0.23 million shares during last trading session. Its last month’s stock price volatility remained 4.95% which for the week approaches 3.75%. The lowest price the stock reached in the last trading day was $40.15 and compares with the $30.90 52-week low. The stock recovered 30.26% since its low point and has performed 20.69% year-to-date.

Previous articleAnalyst Commentary On Antares Pharma, Inc. (ATRS), Approach Resources, Inc. (AREX)
Next articleAnalysts Shared Their Read on 2 Stocks: Century Aluminum Company (CENX), Energous Corporation (WATT)